Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 33 (SLC25A33) is a mitochondrial inner membrane transporter responsible for importing and exporting pyrimidine nucleotides (including uridine, thymidine, guanosine, cytosine, and inosine (deoxy)nucleoside di- and triphosphates) by an antiport mechanism[1][3]. Its primary physiological role is to supply the mitochondrial DNA and RNA synthesis machinery with necessary nucleotide precursors and to participate in mitochondrial genome maintenance and control of respiration and membrane potential[1][3]. SLC25A33 is also linked to regulation of cell proliferation and inflammatory responses, particularly in macrophage activation and sepsis, by modulating mitochondrial genome stability, ROS levels, and the cGAS-STING pathway[2][3][4][7]. Dysfunction is associated with rare human disorders (such as combined oxidative phosphorylation deficiency 8), and its modulation is being explored for targeting inflammation-related pathologies[2][3].
Inhibition of pyrimidine nucleotide transport (e.g., by PLP), reducing mitochondrial DNA synthesis, mitochondrial ROS, and inflammatory cytokine production[2]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 33 (SLC25A33).